- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Clinical evaluations of clobetasone-17-butyrae ointment (Kindavate) on the various facial dermatitis.
-
- ISHII Masamitsu
- Department of Dermatology, Osaka City University Medical School
-
- KOHNO Takeshi
- Department of Dermatology, Osaka City University Medical School
-
- KITAJIMA Junichi
- Department of Dermatology, Osaka City University Medical School
-
- TANII Tsukasa
- Department of Dermatology, Osaka City University Medical School
-
- HOSOI YOKO
- Department of Dermatology, Osaka City University Medical School
-
- SHOJI Akinobu
- Department of Dermatology, Osaka City University Medical School
-
- YORIFUJI Tokiko
- Department of Dermatology, Osaka City University Medical School
-
- ASAI Yoshie
- Department of Dermatology, Osaka City University Medical School
-
- HAMADA Toshio
- Department of Dermatology, Osaka City University Medical School
Bibliographic Information
- Other Title
-
- 顔面の湿しん・皮膚炎群に対する酪酸クロベタゾン(キンダベート)軟こうの臨床効果と副作用に関する検討
Search this article
Description
Clinical efficacy and side actions of 0.05% clobetasone-17-butyrate ointment were evaluated on the various facial dermatitis.<BR>A total of 30 cases, i. e., 17 cases of atopic dermatitis, 4 cases of eczema infantum, 3 cases of seborrheic dermatitis, 2 cases of eczzema vulgare, 2 cases of actinic dermatitis and a case of pruritus cutaneus with eczematization, were examined for a variety of periods from 3 to 175 days. Although an average application period was relatively long 7 weeks, local side actions such as, skin atrophy, teleangiectasia, acne and rosacea-like dermatitis were not at all observed.<BR>Marked or moderate improvement was achieved in 28 out of the whole 30 cases (93%). This high efficacy and low side actions of this remedy indicate the high capability of safety application to the face where steroid side effect troubles tend to occur easily.
Journal
-
- Skin research
-
Skin research 28 (1), 74-81, 1986
Meeting of Osaka Dermatological Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679775736192
-
- NII Article ID
- 130003843453
-
- ISSN
- 1884541X
- 00181390
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed